Literature DB >> 69953

Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis.

A K Lefvert, R Pirskanen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69953     DOI: 10.1016/s0140-6736(77)91506-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Brain stem auditory evoked potentials reflect central nervous system involvement in myasthenia gravis.

Authors:  R Jech; E Růzicka
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

2.  Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

Authors:  A K Lefvert; K Bergström; G Matell; P O Osterman; R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

3.  Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Authors:  M Halbach; V Hömberg; H J Freund
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

4.  Anti-CNS antibodies in neurological and psychiatric disorders.

Authors:  A V Plioplys; J Thibault; J P Bouchard; C Cockburn; R Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 5.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

6.  Absence of central functional cholinergic deficits in myasthenia gravis.

Authors:  S W Lewis; M A Ron; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

7.  Neuropsychological assessment in myasthenia gravis.

Authors:  Emilia J Sitek; Małgorzata M Bilińska; Dariusz Wieczorek; Walenty M Nyka
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.